Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.39 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2775034 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL9000271 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL2029982 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL3129154 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL22156 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL2035594 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL7775057 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL7774934 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL2773155 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL1668243 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116964000-A | Prussian blue positive electrode material, preparation method thereof and Prussian blue positive electrode sheet | 广东邦普循环科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| EP-1778759-B1 | PHOTOSENSITIVE DIELECTRIC RESIN COMPOSITIONS AND THEIR USES | PROMERUS LLC (US) | 2008-11-12 | — | — | EP | claimed |
| EP-1114065-A1 | CELLULOSE MICROFIBRILS WITH MODIFIED SURFACE, PREPARATION METHOD AND USE THEREOF | RHODIA CHIMIE (FR) | 2001-07-11 | — | — | EP | claimed |
| WO-2000015667-A1 | CELLULOSE MICROFIBRILS WITH MODIFIED SURFACE, PREPARATION METHOD AND USE THEREOF | RHODIA CHIMIE (FR) | 2000-03-23 | — | — | WO | claimed |
| US-5958869-A | BASIC AMINO-ACID DERIVATIVES OR SALTS THEREOF OBTAINED BY REACTING GLYCIDYL ETHERS WITH BASIC AMINO ACIDS OR SALTS THEREOF | AJINOMOTO CO., INC. (JP) | 1999-09-28 | — | — | US | claimed |
| US-4469615-A | Water treating compositions | KOHRYU INDUSTRIAL CO. LTD. (JP) | 1984-09-04 | — | — | US | claimed |
| US-6436536-B1 | — | — | None | — | — | US | disclosed |
| JP-60240769-A | — | — | None | — | — | JP | disclosed |
| JP-11171960-A | — | — | None | — | — | JP | disclosed |
| US-20260022104-A1 | AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20260008901-A1 | AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-08 | — | — | US | disclosed |
| EP-4592280-A1 | AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-07-30 | — | — | EP | disclosed |
| EP-4592281-A1 | AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-07-30 | — | — | EP | disclosed |
| EP-0693546-A1 | Refrigerator oil and fluid composition for refrigerator | NIPPON OIL Co. Ltd. (JP) | 1996-01-24 | — | — | EP | disclosed |
| US-5447647-A | Comprise carboxylic esters as base oil and an epoxy compound additive; compatible with new hydrogen containing halocarbons; nonhydrolyzing | NIPPON OIL CO., LTD. (JP) | 1995-09-05 | — | — | US | disclosed |
| EP-0175588-A2 | Novolac based epoxy resin curing agents for use in aqueous systems | INTEREZ, Inc. (a Georgia corporation) (US) | 1986-03-26 | — | — | EP | disclosed |
| JP-S60240769-A | PRODUCTION OF INORGANIC MATERIAL HAVING HYDROPHOBIC SURFACE | NIPPON STEEL CHEM CO LTD | 1985-11-29 | — | — | JP | disclosed |
| US-4469615-A | Water treating compositions | KOHRYU INDUSTRIAL CO. LTD. (JP) | 1984-09-04 | — | — | US | disclosed |
| US-3983171-A | Anionic surface active compositions | L'OREAL (FR) | 1976-09-28 | — | — | US | disclosed |
| US-3959460-A | Cosmetic compositions containing anionic surface active agent containing mono- or polyhydroxylated mono- or poly ether chains and a terminal acid group | L'OREAL (FR) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022104-A1 | AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | ASH2L, PRMT1, RER1 | ALDH1A1 982/4885TDP1 3994/4885SPHK1 4734/4885 |
| US-20260008901-A1 | AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | PRMT1, SRM, BCAT2 | ALDH1A1 514/4885TDP1 2574/4885SPHK1 4300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.